transplantation, liver graft ischemia-reperfusion injury occurs mainly due to
cold preservation and warm reperfusion. In this research, we study the
affection of plasma protein of the donor on liver graft during cold
preservation and warm reperfusion. In this study, 34 liver transplantations
were performed from 2007 to 2010, and the clinical data were collected
retrospectively from the Dongfang Hospital database. 34 specimens were
harvested from 34 liver grafts when graft trimming as Group A and 34 specimens
harvested from the same 34 liver grafts during liver transplantation surgery
but before abdominal closure as B group. All liver tissue specimens were fixed
with 40 g/L neutral formalin, embedded in paraffin. Light microscopy,
transmission electron microscopy, Periodic Acid-Schiff (PAS) stain and immunohistochemical
stain of IgG, IgM, IgA, C3d, C4d, Fib, C1q, and CD61 were used. In this study,
we found that eosinophilic bodies emerged in liver lobes during liver
transplantation which had not been reported previously in the literature. 1)
Protein globules were found exclusively in liver graft specimens. The globules
were round or oval with sharp edges, measured approximately 1.59 to 9.41 μm in
diameter, and were scattered in the liver sinusoids or space of Disse or hepatocyte
cytoplasm, were stained with IgG, IgM, IgA, Fib, C3d by immunohistochemical staining; 2) There was no statistical
significant difference of protein globules number between A group and B group
(P>0.05); 3) IRI score of B group was not
correlated with protein globules number (P>0.05). Protein globules contain plasma
composition, and may form during cold preservation.
S. J. Zhang, C. J. Zhu, Y. F. Zhao, J. Li and W. Z. Guo, “Different Ischemic Preconditioning for Rat Liver Graft: Protection and Mechanism,” Hepatobiliary & Pancreatic Diseases International, Vol. 2, No. 4, 2003, pp. 509-512.
S. Yan, L. M. Jin, Y. X. Liu, L. Zhou, H. Y. Xie and S. S. Zheng, “Outcomes and Mechanisms of Ischemic Preconditioning in Liver Transplantation,” Hepatobiliary & Pancreatic Diseases International, Vol. 9, No. 4, 2010, pp. 346-354.
H. Shimizu, M. Miyazaki, H. Ito, K. Nakagawa, S. Ambiru, A. Kato, et al., “Mechanism of Cold Ischemia-Reperfusion Induced Graft Injury after Orthotopic Liver Transplantation in Rats,” Hepatogastroenterology, Vol. 48, No. 37, 2001, pp. 216-219.
J. W. Kupiec-Weglinski and R. W. Busuttil, “Ischemia and Reperfusion Injury in Liver Transplantation,” Transplantation Proceedings, Vol. 37, No. 4, 2005, pp. 1653-1656. doi:10.1016/j.transproceed.2005.03.134
C. Y. Feng, “Research on Humoral and Cellular Immune Markes of Liverg Graft before and after Reperfusion,” Master’s Thesis, Fujian Medical University, Fuzhou, 2009. http://epub.cnki.net/grid2008/brief/detailj.aspx?filename=2009150523.nh&dbname=CMFD2009
N. S. Goldstein, J. Hart and K. J. Lewin, “Diffuse Heap-Tocyte Ballooning in Liver Biopsies from Orthotopic Liver Transplant Patients,” Histopathology, Vol. 18, No. 4, 1991, pp. 331-338.
L. Luo, Y. Chen and X.-L. Ji, “Clinicopathological Observation and Analysis of Donor Liver and Biopsy in Liver Transplantation,” Chinese Journal of Hepatobiliary Surgery, Vol. 15, No. 12, 2009, pp. 885-887.
S. H. Kim and H. J. Jeong, “Glomerular C4d Deposition Indicates in Situ Classic Complement Pathway Activation, but Is Not a Marker for Lupus Nephritis Activity,” Yonsei Medical Journal, Vol. 44, No. 1, 2003, pp. 75-80.
X. Bu, Z. Zheng, Y. Yu, L. Zeng and Y. Jiang, “Significance of C4d Deposition in the Diagnosis of Rejection after Liver Transplantation,” Transplantation Proceedings, Vol. 38, No. 5, 2006; pp. 1418-1421.
X. Bu, Z. Zheng, C. Wang and Y. Yu, “Significance of C4d Deposition in the Follicular Lymphoma and MALT Lymphoma and Their Relationship with Follicular Dendritic Cells,” Pathology—Research and Practice, Vol. 203, No. 3, 2007, pp. 163-167.
K. Murata and W. M. Baldwin 3rd, “Mechanisms of Complement Activation, C4d Deposition, and Their Contribution to the Pathogenesis of Antibody-Mediated Rejection,” Transplantation Reviews (Orlando), Vol. 23, No. 3, 2009, pp. 139-150. doi:10.1016/j.trre.2009.02.005
P. S. Hair, J. Q. Gronemus, K. B. Crawford, V. P. Salvi, K. M. Cunnion, N. M. Thielens, et al., “Human Astrovirus Coat Protein Binds C1q and MBL and Inhibits the Classical and Lectin Pathways of Complement Activation,” Molecular Immunology, Vol. 47, No. 4, 2010, pp. 792-798. doi:10.1016/j.molimm.2009.10.006
L. T. Roumenina, M. Radanova, B. P. Atanasov, K. T. Popov, S. V. Kaveri, S. Lacroix-Desmazes, et al., “Heme Interacts with c1q and Inhibits the Classical Complement Pathway,” The Journal of Biological Chemistry, Vol. 286, No. 18, 2011, pp. 16459-16469.
A. Mateo, C. O. Pintado, J. P. de la Lastra, R. Dusinsky, M. Simon, J. Naessens, et al., “Ruminant Cluster CD41/ CD61,” Veterinary Immunology and Immunopathology, Vol. 52, No. 4, 1996, pp. 251-253.
A. Merono, C. Lucena, A. López, J. J. Garrido, L. L. de Pérez and D. Llanes, “Immunohistochemical Analysis of Beta3 Integrin (CD61): Expression in Pig Tissues and Human Tumors,” Histology and Histopathology, Vol. 17, No. 2, 2002, pp. 347-352.
C. Fondevila, R. W. Busuttil and J. W. Kupiec-Weglinski, “Hepatic Ischemia/Reperfusion Injury—A Fresh Look,” Experimental and Molecular Pathology, Vol. 72, No. 4, 2003, pp. 86-93. doi:10.1016/S0014-4800(03)00008-X
T. Okazaki, A. Nakahashi, T. Uchiyama, A. Imoto, K. Morikawa, T. Okano, et al., “Composition of Cryoglobulin and Cryoprecipitate,” Clinical Chemistry and Laboratory Medicine, Vol. 47, No. 9, 2009, pp. 1161-1163.
Chapter 2, “Anatomy and Physiology of the Liver. Arjan van der Plaats. The Groningen Hypothermic Liver Perfusion System for Improved Preservation in Organ Transplantation,” 2005.
H. F. Eggink, N. Hofstee, C. H. Gips, R. A. Krom and H. J. Houthoff, “Histopathology of Serial Graft Biopsies from Liver Transplant Recipients,” American Journal of Pathology, Vol. 114, No. 1, 1984, pp. 18-31.
T. Inagaki, S. Kobayashi, N. Ozeki, M. Suzuki, Y. Fukuzawa, K. Shimizu, et al., “Ultrastructural Identification of Light Microscopic Giant Mitochondria in Alcoholic Liver Disease,” Hepatology, Vol. 15, No. 1, 1992, pp. 46-53.
P. Fickert, M. Trauner, A. Fuchsbichler, C. Stumptner, K. Zatloukal and H. Denk, “Mallory Body Formation in Primary Biliary Cirrhosis Is Associated with Increased Amounts and Abnormal Phosphorylation and Ubiquitination of Cytokeratins,” Journal of Hepatology, Vol. 38, No. 4, 2003, pp. 387-394.
J. A. Burrows, L. K. Willis and D. H. Perlmutter, “Chemical Chaperones Mediate Increased Secretion of Mutant Alpha 1-Antitrypsin (alpha 1-AT) Z: A Potential Pharmacological Strategy for Prevention of Liver Injury and Emphysema in Alpha 1-AT Deficiency,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 4, 2000, pp. 1796-1801.
P. Gómez-Garre, E. Gutiérrez-Delicado, C. Gómez-Abad, J. Morales-Corraliza, V. E. Villanueva and S. R. de Córdoba, “Hepatic Disease as the First Manifestation of Progressive Myoclonus Epilepsy of Lafora,” Neurology, Vol. 68, No. 17, 2007, pp. 1369-1373.